For today’s edition, Google’s random number generator chose Week 7, the Steelers’ 33-31 Thursday Night Football loss to the ...

Want to get your very own quizzes and posts featured on BuzzFeed’s homepage and app? Become a Community Contributor.

This article is part of the series “Don't ask AI, ask a peer,” a collaboration among Global Voices, the Association for Progressive Communication, and GenderIT. The series aims to re-emphasise the ...

Ray Solley, former Executive Director of Bend’s Tower Theatre, hosts a new interview series using three levels of ice-breaker questions randomly drawn by each guest. By listening and posing follow-up ...

Baseball reporter Angie Mentink is handling her viral 15 seconds with grace, poking fun at herself after a video was posted on social media showing her using Google Gemini to formulate postgame ...

You can interact with the 3D models and adjust variables in real time. You can interact with the 3D models and adjust variables in real time. is a news writer who covers the streaming wars, consumer ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...

Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...

More than 100 years ago Hungarian-born mathematician George Pólya found himself trapped in a loop of social awkwardness. A professor at the Swiss Federal Institute of Technology Zurich, he enjoyed ...

Generate Biomedicines, Inc. (GENB) has filed to raise public capital in an IPO to advance its pipeline of treatment candidates, according to an SEC filing. The company is developing treatments for ...

Generate:Biomedicines' anti-TSLP antibody GB-0895 is currently being evaluated in a pair of phase 3 studies for severe asthma. (Stock photo/Getty Images) Clinical-stage antibody company ...